USA Trends and Developments
Trends and Developments Contributed by: David McIntosh, Matt Byron, Ryan Kramer, Sabrina Kim and Zoe Dettelbach Ropes & Gray LLP
Ropes & Gray LLP is home to one of the world’s pre-eminent life sciences groups, with a global platform for innovators at every stage of the development life cycle. The firm’s collaborative approach – spanning more than 25 practice ar- eas and touching all offices around the world – offers one of the largest and most experienced industry-specific teams, comprising more than
300 lawyers, subject-matter experts and techni- cal advisers who deliver sophisticated transac- tional, regulatory, IP, and litigation and enforce- ment strategies to position industry innovators and investors for success. The Ropes & Gray team is sought after to lead clients in navigating the complex legal landscape in which the life sciences industry operates.
Authors
David McIntosh is a partner in Ropes & Gray LLP’s life sciences and IP transactions practice groups. Recognised by Chambers and Partners and other industry publications as a leading practitioner in his field, David advises a wide range of companies, investors and institutions in the life sciences industry on strategic transactions involving IP, with particular focus on strategic collaborations, technology licensing, M&A, joint ventures, supply and distribution arrangements, and co-promotion and marketing agreements. He has led recent transactions for Johnson & Johnson, Avidity Biosciences, Monte Rosa Therapeutics, Novavax Inc, ImmunoGen, HotSpot Therapeutics, Adaptimmune Therapeutics, and the Broad Institute.
Matt Byron is a partner in Ropes & Gray LLP’s strategic M&A group and focuses his practice on representing public and private companies as well as private equity sponsors in a
broad range of life sciences, pharma, medtech and other healthcare transactions, including large-cap and middle-market acquisitions, divestitures, joint ventures, carve-out transactions, options to acquire, and collaborations. Matt has led recent transactions for Janssen Pharmaceuticals, Vertex Pharmaceuticals, Regeneron, Ginkgo Bioworks, DePuy Synthes, J&J Medtech, Fibrogen, and Biogen.
389 CHAMBERS.COM
Powered by FlippingBook